Short-course vaginal cuff brachytherapy (VCB) is noninferior to standard regimens for short-term quality of life in people with early-stage endometrial cancer, according to a study published online ...

Two new measures tied to outcomes drawn from data in the CLEAR phase 3 trial will be presented during the ASCO Genitourinary ...

The FDA has granted breakthrough device designation to the ACR-368 OncoSignature assay for use in endometrial cancer.

The single-cell landscape of small cell neuroendocrine cervical carcinoma revealed the tumor heterogeneity and the molecular subtypes, laying the foundation for exploring tumor etiology ...

In cattle, spontaneous endometrial carcinoma is typically solitary, and histologically, it is often adenocarcinoma, frequently accompanied by the formation of dense fibrous tissue. However, due to the ...

Method: Two-sample Mendelian randomization was employed to probe the causal association between lipid traits and endometrial carcinoma. Drug-target Mendelian randomization was also utilized to ...

1Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, P. R. China. 2Jiangsu Key Laboratory ...

The Keytruda plus Lenvima combination is currently approved in the United States, Europe, Japan and other countries for treating certain types of advanced endometrial carcinoma and advanced renal cell ...

Thin Endometrium Explained: The endometrium is the innermost lining of the uterus that plays a crucial role in the reproductive process. Every month, the endometrial lining thickens in preparation ...

AI decision support system non-homogenously influences clinical decisions in dynamic treatment regimen, as it depends on several factors including prior knowledge, preference, disease type ...

known as advanced renal cell carcinoma, and certain types of advanced endometrial carcinoma — a type of uterine cancer. The safety profile of the combination was consistent with that observed in ...

1 The Keytruda plus Lenvima combination has been approved for advanced renal cell carcinoma and for patients with advanced endometrial carcinoma that is mismatch repair proficient or not ...